T. Rowe Price Associates’s Octave Specialty Group OSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $728K | Buy |
116,612
+14,647
| +14% | +$76.3K | ﹤0.01% | 2454 |
|
|
2026
Q1 | $475K | Buy |
101,965
+31,024
| +44% | +$178K | ﹤0.01% | 2481 |
|
|
2025
Q4 | $552K | Hold |
70,941
| – | – | ﹤0.01% | 2345 |
|
|
2025
Q3 | $592K | Buy |
70,941
+18,736
| +36% | +$158K | ﹤0.01% | 2299 |
|
|
2025
Q2 | $371K | Buy |
52,205
+3,332
| +7% | +$24.8K | ﹤0.01% | 2441 |
|
|
2025
Q1 | $428K | Buy |
48,873
+2,038
| +4% | +$21.5K | ﹤0.01% | 2312 |
|
|
2024
Q4 | $593K | Buy |
46,835
+7,042
| +18% | +$84.9K | ﹤0.01% | 2215 |
|
|
2024
Q3 | $447K | Buy |
39,793
+415
| +1% | +$4.85K | ﹤0.01% | 2297 |
|
|
2024
Q2 | $505K | Buy |
39,378
+973
| +3% | +$14.8K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $601K | Buy |
38,405
+1,861
| +5% | +$29.3K | ﹤0.01% | 2137 |
|
|
2023
Q4 | $603K | Buy |
36,544
+849
| +2% | +$11.8K | ﹤0.01% | 2097 |
|
|
2023
Q3 | $431K | Buy |
35,695
+1,180
| +3% | +$15.9K | ﹤0.01% | 2180 |
|
|
2023
Q2 | $492K | Buy |
34,515
+446
| +1% | +$6.53K | ﹤0.01% | 2141 |
|
|
2023
Q1 | $528K | Sell |
34,069
-4,090
| -11% | -$66.2K | ﹤0.01% | 2083 |
|
|
2022
Q4 | $665K | Sell |
38,159
-5,736
| -13% | -$85.2K | ﹤0.01% | 1997 |
|
|
2022
Q3 | $560K | Buy |
43,895
+835
| +2% | +$11.1K | ﹤0.01% | 2066 |
|
|
2022
Q2 | $489K | Sell |
43,060
-2,345
| -5% | -$22.3K | ﹤0.01% | 2228 |
|
|
2022
Q1 | $472K | Buy |
45,405
+931
| +2% | +$12.6K | ﹤0.01% | 2366 |
|
|
2021
Q4 | $714K | Buy |
44,474
+2,000
| +5% | +$31.4K | ﹤0.01% | 2204 |
|
|
2021
Q3 | $608K | Buy |
42,474
+233
| +0.6% | +$3.33K | ﹤0.01% | 2287 |
|
|
2021
Q2 | $661K | Sell |
42,241
-7,067
| -14% | -$114K | ﹤0.01% | 2249 |
|
|
2021
Q1 | $825K | Buy |
49,308
+41
| +0.1% | +$670 | ﹤0.01% | 2148 |
|
|
2020
Q4 | $758K | Buy |
49,267
+27,294
| +124% | +$402K | ﹤0.01% | 2060 |
|
|
2020
Q3 | $281K | Sell |
21,973
-6,100
| -22% | -$78.6K | ﹤0.01% | 2311 |
|
|
2020
Q2 | $402K | Buy |
28,073
+118
| +0.4% | +$1.73K | ﹤0.01% | 2135 |
|
|
2020
Q1 | $345K | Buy |
27,955
+300
| +1% | +$5.75K | ﹤0.01% | 2148 |
|
|
2019
Q4 | $597K | Buy |
27,655
+1,791
| +7% | +$36.7K | ﹤0.01% | 2093 |
|
|
2019
Q3 | $506K | Buy |
25,864
+9,218
| +55% | +$169K | ﹤0.01% | 2096 |
|
|
2019
Q2 | $280K | Buy |
16,646
+134
| +0.8% | +$2.29K | ﹤0.01% | 2320 |
|
|
2019
Q1 | $299K | Buy |
16,512
+100
| +0.6% | +$1.91K | ﹤0.01% | 2290 |
|
|
2018
Q4 | $283K | Buy |
+16,412
| New | +$301K | ﹤0.01% | 2309 |
|
|
2017
Q4 | – | Sell |
-23,926
| Closed | -$413K | – | 2565 |
|
|
2017
Q3 | $413K | Hold |
23,926
| – | – | ﹤0.01% | 2161 |
|
|
2017
Q2 | $415K | Buy |
23,926
+4,400
| +23% | +$78.2K | ﹤0.01% | 2129 |
|
|
2017
Q1 | $368K | Buy |
+19,526
| New | +$411K | ﹤0.01% | 2175 |
|
|
2016
Q3 | – | Sell |
-17,000
| Closed | -$280K | – | 2527 |
|
|
2016
Q2 | $280K | Hold |
17,000
| – | – | ﹤0.01% | 2207 |
|
|
2016
Q1 | $269K | Sell |
17,000
-3,800
| -18% | -$55K | ﹤0.01% | 2196 |
|
|
2015
Q4 | $293K | Buy |
+20,800
| New | +$320K | ﹤0.01% | 2169 |
|
Other funds holding OSG
WSL
PGCM
TAM
BCC
T. Rowe Price Associates's OSG Position: Q2 2026 in Review
T. Rowe Price Associates increased its Octave Specialty Group (OSG) stake by 14% in Q2 2026, buying an estimated $76.3K and bringing the position to 116,612 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.
T. Rowe Price Associates first reported a position in OSG in Q4 2015 and has held it in 37 quarters since. The position peaked at $825K in Q1 2021. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.
- T. Rowe Price Associates held 116,612 shares of Octave Specialty Group worth $728K as of Q2 2026.
- T. Rowe Price Associates bought 14,647 Octave Specialty Group shares in Q2 2026, an estimated $76.3K.
- Octave Specialty Group made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2454 holding.
- T. Rowe Price Associates first reported a position in Octave Specialty Group in Q4 2015 and has held it in 37 quarters since.
- T. Rowe Price Associates's Octave Specialty Group position peaked at $825K in Q1 2021.
- 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.